Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies12
  • 7D-1.6%
  • 3M28.4%
  • 1Y46.8%
  • YTD27.8%

Over the last 7 days, the Life Sciences industry has dropped 1.6%, driven by a pullback from MedCap of 11%. This takes the industry's 12 month performance to a gain of 47%. As for the next few years, earnings are expected to grow by 47% per annum.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024SEK 48.3bSEK 16.7b-SEK 1,128,120,510.0060.3x-42.8x2.9x
Sun, 23 Jun 2024SEK 42.6bSEK 16.3b-SEK 1,188,686,510.0055x-35.9x2.6x
Tue, 21 May 2024SEK 42.7bSEK 16.3b-SEK 1,188,529,510.0060.3x-35.9x2.6x
Thu, 18 Apr 2024SEK 37.5bSEK 16.0b-SEK 1,122,792,213.0034.6x-33.4x2.3x
Sat, 16 Mar 2024SEK 38.7bSEK 16.0b-SEK 1,123,139,210.0033.4x-34.5x2.4x
Mon, 12 Feb 2024SEK 39.7bSEK 15.8b-SEK 1,473,823,683.0056.5x-26.9x2.5x
Wed, 10 Jan 2024SEK 37.4bSEK 15.5b-SEK 1,393,723,683.0045.5x-26.9x2.4x
Fri, 08 Dec 2023SEK 36.8bSEK 15.5b-SEK 1,393,723,683.0045x-26.4x2.4x
Sun, 05 Nov 2023SEK 31.0bSEK 15.4b-SEK 1,256,647,710.0034.2x-24.7x2x
Tue, 03 Oct 2023SEK 26.8bSEK 15.1b-SEK 1,134,516,711.0039.2x-23.6x1.8x
Thu, 31 Aug 2023SEK 31.0bSEK 15.1b-SEK 1,138,067,831.0042.1x-27.2x2.1x
Sat, 29 Jul 2023SEK 33.2bSEK 14.9b-SEK 239,671,038.0047.3x-138.3x2.2x
Mon, 26 Jun 2023SEK 35.7bSEK 14.6b-SEK 172,476,038.0038.7x-207.1x2.4x
Wed, 24 May 2023SEK 40.3bSEK 14.6b-SEK 175,374,038.0041.3x-229.6x2.8x
Fri, 21 Apr 2023SEK 31.7bSEK 14.6b-SEK 59,425,459.0034.2x-533.4x2.2x
Sun, 19 Mar 2023SEK 34.0bSEK 14.6b-SEK 57,185,459.0031.9x-595.1x2.3x
Tue, 14 Feb 2023SEK 41.1bSEK 14.4bSEK 827.0m38x49.6x2.8x
Thu, 12 Jan 2023SEK 40.9bSEK 14.2bSEK 943.9m41x43.3x2.9x
Sat, 10 Dec 2022SEK 39.1bSEK 14.1bSEK 944.3m41.4x41.4x2.8x
Mon, 07 Nov 2022SEK 33.6bSEK 13.9bSEK 761.3m48.6x44.1x2.4x
Wed, 05 Oct 2022SEK 35.0bSEK 13.5bSEK 750.9m49.3x46.6x2.6x
Fri, 02 Sep 2022SEK 36.0bSEK 13.5bSEK 749.8m50x47.9x2.7x
Sun, 31 Jul 2022SEK 46.2bSEK 13.2bSEK 667.7m44.8x69.1x3.5x
Tue, 28 Jun 2022SEK 45.7bSEK 13.2bSEK 753.4m40.6x60.7x3.5x
Thu, 26 May 2022SEK 54.8bSEK 13.2bSEK 753.3m47x72.7x4.1x
Sat, 23 Apr 2022SEK 61.7bSEK 11.8bSEK 718.3m53.9x85.9x5.2x
Mon, 21 Mar 2022SEK 64.5bSEK 11.8bSEK 745.4m55.4x86.5x5.5x
Wed, 16 Feb 2022SEK 55.4bSEK 11.4bSEK 784.4m46.1x70.7x4.8x
Fri, 14 Jan 2022SEK 70.0bSEK 10.8bSEK 786.3m47.6x89x6.5x
Sun, 12 Dec 2021SEK 80.6bSEK 10.8bSEK 787.8m51.9x102.3x7.5x
Tue, 09 Nov 2021SEK 95.6bSEK 10.5bSEK 892.5m54.1x107.1x9.1x
Thu, 07 Oct 2021SEK 89.8bSEK 9.9bSEK 853.6m50.8x105.2x9.1x
Sat, 04 Sep 2021SEK 99.6bSEK 9.9bSEK 853.6m56.1x116.7x10.1x
Mon, 02 Aug 2021SEK 93.0bSEK 9.9bSEK 853.6m52.2x108.9x9.4x
Price to Earnings Ratio

108.9x


Total Market Cap: SEK 93.0bTotal Earnings: SEK 853.6mTotal Revenue: SEK 9.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -26.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.57%
Healthcare0.77%
Life Sciences-1.57%
Clinical Research and Equipment-1.57%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 156.302.4%
+SEK 438.7m		76.4%PE161.4x
BIOT BiotageSEK 190.800.4%
+SEK 56.0m		44.5%PE60.8x
AROC AroCellSEK 0.4812.2%
+SEK 12.0m		-7.0%PS2.5x
PRO PromimicSEK 35.400.9%
+SEK 5.6m		11.7%PS15.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALIF B

SEK 156.30

AddLife

7D

2.4%

1Y

76.4%

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26
AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

MCAP

SEK 528.00

MedCap

7D

-11.0%

1Y

94.1%

AROC

SEK 0.48

AroCell

7D

12.2%

1Y

-7.0%

PEXA B

SEK 0.36

PExA

7D

-13.0%

1Y

-38.6%

BIOT

SEK 190.80

Biotage

7D

0.4%

1Y

44.5%

MAGLE

SEK 43.40

Magle Chemoswed Holding

7D

-2.7%

1Y

24.0%

ATANA

SEK 0.071

Attana

7D

-4.1%

1Y

-70.0%

BICO

SEK 43.08

BICO Group

7D

-6.4%

1Y

-6.5%

CLINE B

SEK 0.06

Cline Scientific

7D

-19.3%

1Y

-84.4%

GENO

SEK 28.40

Genovis AB (publ.)

7D

-4.1%

1Y

-38.1%

PRO

SEK 35.40

Promimic

7D

0.9%

1Y

11.7%

LEVBIO

SEK 0.29

Level Bio

7D

-8.1%

1Y

-54.1%